The Runway Is Not the Same as Liquidity: Negotiating a Founder Venture Debt Term Sheet
This post uses hypothetical scenarios for illustrative purposes only. It does not describe any actual client, transaction, or representation, and is not legal advice.
Fictional educational case study. HelioForge Analytics, Inc. and every person, fact, number and transaction described below are fictional. This article illustrates how EF-097 may organize a financing discussion. It is not legal, tax, accounting, investment or financial advice, and it is not a substitute for counsel reviewing the actual deal.
Venture debt can look inexpensive when a team focuses on the headline interest rate. The more useful founder question is whether the complete structure—draw timing, fees, warrant value, amortization, covenants and closing conditions—protects the company’s operating plan when the equity financing arrives later than expected.
This case study follows a founder team through that analysis. It shows how to use the Founder Venture Debt Term Sheet Extended Form (EF-097) as a decision record, not merely a list of economic terms.
The Fictional Company
| Item | Case fact |
|---|---|
| Company | HelioForge Analytics, Inc., a Delaware corporation |
| Business | Climate-risk analytics sold to infrastructure operators |
| Stage | Series A; approximately $7.2 million annual recurring revenue |
| Cash at signing | $4.6 million |
| Current net burn | $650,000 per month |
| Equity plan | Series B targeted for month 9; downside case assumes month 15 |
| Proposed debt | $8 million: $4 million at closing and $4 million delayed draw |
| Headline pricing | Term SOFR plus 8.50%; 1% origination fee; 4% final payment |
| Equity feature | Warrant coverage equal to 5% of funded principal, priced at the next preferred round |
| Collateral proposal | Broad asset lien; core registered intellectual property subject to a negative pledge rather than a present lien |
HelioForge wants the facility to extend runway through a Series B. The board initially describes the proposal as “an extra twelve months of runway.” That statement is directionally useful but incomplete. Cash runway measures time at an assumed burn rate. Covenant liquidity measures whether the company remains above a contractual threshold, often after exclusions and subject to testing dates. Debt service and fees also change the burn profile.
The Problem Hidden by the Headline
The lender’s first term sheet offers twelve months of interest-only payments, followed by twenty-four months of amortization. The delayed tranche expires in month 10 and is conditioned on both $10 million of annual recurring revenue and “satisfactory evidence” of a qualified equity financing process. The minimum-liquidity covenant begins in month 7 at $2 million.
Management’s base model assumes the Series B closes in month 9. Under that case, the delayed tranche is available and the company remains comfortably above the liquidity covenant. In the downside case, however, the Series B slips to month 15, the revenue milestone is reached only in month 11, and the delayed tranche has already expired. Amortization begins in month 13. The company can still show more than four months of accounting runway, but it breaches the $2 million liquidity covenant in month 14.
That is the central lesson: runway and covenant headroom are related, but they are not the same calculation.
Why EF-097 Matters
EF-097 makes the team complete the economics and the legal architecture together. For this transaction, the most important controls are:
- a tranche table showing amount, availability period, objective milestones and documentary conditions;
- a total-cost schedule that includes fees, final payment, warrant dilution and prepayment economics;
- a collateral matrix that separates current liens, exclusions, negative pledges and any springing lien;
- a covenant summary tied to definitions and testing dates; and
- base, downside and severe-downside runway cases.
The form also records which provisions are intended to be binding. That prevents a nonbinding commercial outline from accidentally obscuring binding confidentiality, exclusivity, expense or governing-law provisions.
How to Complete the Form
Step 1: Build the Facility and Tranche Table
List each tranche separately. For HelioForge, the first row is a $4 million initial advance available at closing. The second row is a $4 million delayed advance. Do not write only “subject to milestones.” State the milestone, the measurement date, the evidence, who determines satisfaction, whether discretion must be reasonable, and what happens if a condition is missed for reasons outside the company’s control.
HelioForge’s team revises the delayed-draw condition from “satisfactory financing process” to an objective package: board-approved operating plan, at least $9.5 million annual recurring revenue measured under the agreed definition, no payment default and delivery of an updated compliance certificate. The availability period moves from month 10 to month 15.
Step 2: Complete the All-In Cost Schedule
The finance team models at least the following:
| Cost component | Illustrative input | Founder question |
|---|---|---|
| Initial funded principal | $4,000,000 | Is interest charged only on funded amounts? |
| Origination fee | $80,000 | Is the fee based on committed or funded capital? |
| Final payment | 4% of funded principal | Is it due on maturity, prepayment, acceleration or every repayment? |
| Legal and diligence costs | $90,000 cap | Is there a cap and an invoice-support requirement? |
| Warrant coverage | 5% of funded principal | What valuation or share price determines the number of shares? |
| Prepayment fee | 3% / 2% / 1% | Does a refinancing or acquisition trigger it? |
The team estimates the warrant’s value using several equity outcomes. That estimate is not presented as a prediction; it is a comparison tool. The board receives both cash cost and dilution scenarios.
Step 3: Test the Payment Timeline
Map interest-only months, amortization start, maturity, final payment and prepayment premiums on the same timeline as the operating model. In HelioForge’s downside case, amortization begins before the Series B. The company asks for an automatic six-month interest-only extension if it reaches $10 million annual recurring revenue and remains above the agreed liquidity level, with no continuing default.
Step 4: Define Liquidity Before Quoting It
“Cash” may exclude restricted cash, cash held outside approved accounts, trapped foreign cash or amounts subject to control restrictions. HelioForge has $600,000 in a foreign subsidiary and a $300,000 processor reserve. The team cannot assume either amount counts.
The term sheet should identify the expected definition and flag it for confirmation in the definitive agreement. The model then uses the same definition. A covenant is not safely analyzed if the spreadsheet and the legal document count different dollars.
Step 5: Separate Current and Contingent IP Rights
The collateral schedule records:
- assets subject to a present lien;
- excluded assets and the reason for each exclusion;
- core IP subject only to a negative pledge;
- ordinary-course customer and channel licenses that remain permitted; and
- any objective trigger for a future IP lien.
For HelioForge, the founder team rejects language that could be read as granting a present IP lien while calling it a negative pledge. If the parties later choose a springing lien, the trigger, notice, cure period, activation document and filing mechanics must be explicit.
Step 6: Build the Covenant Headroom Table
The team runs monthly calculations through maturity under three cases:
| Month / case | Base case cash | Downside cash | Severe-downside cash | Minimum liquidity | Result |
|---|---|---|---|---|---|
| Month 9 | $6.8M | $4.1M | $3.3M | $2.0M | Pass in all cases |
| Month 13 | $7.4M | $2.7M | $1.9M | $2.0M | Severe case fails |
| Month 15 | $8.1M | $1.8M | $0.9M | $2.0M | Downside and severe cases fail |
This does not tell the board whether to accept the deal. It tells the board where negotiation, contingency planning or additional equity support is needed.
Step 7: Record Binding Terms and Open Items
The signature section should identify which provisions are binding and which remain subject to definitive documentation. The open-items list should name an owner and deadline for every unresolved point, including warrant pricing, milestone evidence, IP treatment, expense cap, account-control timing and any investor approval.
The Negotiated Result
HelioForge does not simply demand “more flexibility.” It proposes measurable alternatives:
- a month-15 delayed-draw expiration;
- a revenue milestone defined by the company’s consistently applied subscription policy;
- a six-month interest-only extension upon an objective performance test;
- a $2 million minimum-liquidity covenant that begins only after the second tranche is funded;
- a capped expense reimbursement supported by invoices;
- a negative pledge over core IP with no present grant language; and
- a warrant share-price mechanism with a valuation cap and a maximum share count.
The lender accepts some points and modifies others. The final term sheet still requires counsel to translate the business deal into definitive documents, but the board now understands the tradeoffs it approved.
Risk-Control Table
| Issue | What can go wrong | EF-097 control | Specialist or approval gate |
|---|---|---|---|
| Delayed draw | Capital expires before it is needed | Objective milestone and availability table | CFO model; lender confirmation |
| Liquidity covenant | Company counts cash the agreement excludes | Defined-term and headroom review | Finance and transaction counsel |
| Warrant dilution | Coverage looks small but converts into excessive shares | Scenario table, cap and share-price mechanics | Board, investor-rights and tax review |
| IP package | “Negative pledge” language grants a present lien | Separate collateral choices and activation mechanics | IP and secured-transactions counsel |
| Fees | Final payment or expenses apply more broadly than expected | All-in cost schedule | Finance and counsel |
| Exclusivity | Company loses financing alternatives too early | Binding-term inventory and expiration | Board and counsel |
Common Mistakes
- Modeling interest but omitting final payments, legal expenses and warrants.
- Treating an undrawn commitment as if it were unrestricted cash.
- Accepting milestones that depend on unbounded lender discretion.
- Describing the liquidity covenant without reproducing its operative definition.
- Allowing the delayed-draw period to end before the downside financing date.
- Failing to cap warrant shares or address stock splits and future financing prices.
- Assuming the term sheet’s collateral summary will automatically be preserved in the loan agreement.
- Signing exclusivity before the board understands the alternatives and closing path.
Questions for the Founder and Board
- What event is the debt financing intended to bridge, and how late can that event occur?
- Does each draw condition depend on facts the company can measure and prove?
- What is the lowest monthly covenant headroom in the downside case?
- What cash is excluded from the liquidity definition?
- When does amortization begin relative to the expected equity financing?
- What is the maximum cash cost and maximum potential dilution?
- Which assets are subject to present liens, negative pledges or contingent liens?
- What approvals, consents or waivers are required before signing or funding?
AI-Assisted Completion Workflow
An AI tool can help organize the first pass, but it should not decide legal positions or certify facts. Provide the board-approved operating model, capitalization table, proposed term sheet, charter, investor-rights documents, existing debt schedule and IP summary. Remove secrets that the tool is not authorized to receive.
Use an instruction such as:
Using only the supplied materials, prepare a completion draft of EF-097. Separate quoted terms from assumptions. Build facility, cost, collateral, covenant and approval tables. Calculate no legal conclusions. Flag inconsistent definitions, missing evidence, discretionary conditions, uncapped economics and any term that requires board, investor, tax, IP or secured-transactions review. Do not invent facts. Return an open-items list with an owner and source for every unresolved entry.
Human reviewers should trace every populated fact to a source, independently verify calculations and compare the signed term sheet against the definitive documents.
Do Not Use This Approach When
Do not use a term-sheet completion exercise as a substitute for definitive-document review, solvency analysis, tax advice, regulatory advice, fiduciary analysis or approval under the company’s governing documents. A distressed company, regulated borrower, cross-border group, company with material government grants, or company pledging licensed or jointly owned IP requires additional specialist work.
What the Team Should Do Next
After the term sheet is approved, transfer each negotiated point into a definitive-document issues list. Build the loan agreement, disclosure schedules, perfection certificate, board and investor approvals, funding certificate and closing checklist from the same verified data set. Assign an owner for each condition and preserve the approved model as part of the board record.
Related Form
This case study accompanies EF-097 — Founder Venture Debt Term Sheet Extended Form, part of the firm’s fundraising and investor forms. Use the reviewed Word form for matter work; use this article as a teaching and issue-spotting guide.
Website Posting Disclaimer
This publication is general educational information based on a fictional scenario. It does not create an attorney-client relationship and should not be relied on as legal advice. Financing terms, enforceability, perfection, tax consequences, fiduciary duties and required approvals depend on the actual documents, facts and jurisdictions. Engage qualified counsel before negotiating, approving, signing or funding any transaction.
If you are negotiating a venture debt term sheet and want the full cash and equity cost modeled before you sign, feel free to reach out to our firm manager, Magda, at Magda@montague.law, or fill out our contact form. Mention you read this post.

